Therapy » Search Articles by Keyword

Found: 48 articles

Article	Edition
Minushkina L.O., Brazhnik V.A., Averkova A.O., Rogozhina A.A., Evdokimova M.A., Korolyova O.S., Sizgunov D.S., Zubova E.A., Karmanchikova E.A., Galyavich A.S., Khasanov N.R., Ivantsov E.N., Magamedkerimova F.A., Chichkov Yu.M., Chichkova M.A., Kovalenko N.V., Tereshchenko S.N., Koziolova N.A., Glezer M.G., Boeva O.I., Khorolets E.V., Konstantinov V.O., Guliyev R.R., Zateyshchikov D.A. Acute coronary syndrome in patients with diabetes mellitus: unified data of multicenter observational trials ORACLE I and ORACLE II	№1 / 2019
Z.K. Basieva, E.A. Shavlokhova, E.V. Mulukhova, A.Yu. Kekhoeva Features of reflux esophagitis in patients with gastroesophageal reflux disease combined with diabetes mellitus 1 and 2 type	№2 / 2018
A.A. Pilipovich, Al.B. Danilov Role of В group vitamins in the therapy of diabetes melitus complications	№7 / 2017
L.V. Kondratieva, T.V. Popkova, Ye.L. Nasonov Prevalence of traditional risk factors for type 2 diabetes mellitus in patients with rheumatoid arthritis	№4 / 2017
I.G. Kayukov, A.M. Yesayan Patient with comorbidity. Pathogenetic principles of antimicrobial treatment of urinary tract infections in diabetic patients	№2 / 2017
T.Yu. Demidova, I.N. Drozdova Influence of fenofibrate on dyslipidemia and diabetic polyneuropathy in patients with diabetes mellitus type 2	№4 / 2016
T.A. Meleshkevich, Ye.I. Luchina, M.Ye. Shevchenko Diabetic polyneuropathy. Briefly about the main	№4 / 2016
T.Yu. Demidova The role of glimepiride in the modern combined hypoglycemic therapy of diabetes mellitus type 2	№3 / 2016
A.V. Budnevsky, B.B. Romashov, N.V. Polyakova, Ye.Yu. Malysh Actual issues of pathogenesis, clinic and treatment of chronic obstructive pulmonary disease and diabetes	№1 / 2016
B.I. Valitov Therapeutic patient education – an integral element of a comprehensive approach to the treatment of diabetes	№4 / 2015
F.V. Valeeva, Z.R. Alimetova Management of patients with gestational diabetes mellitus	№4 / 2015
T.Yu. Demidova, S.Ye. Isaeva Should sulfonylureas remain the drugs of first choice in addition to metformin?	№4 / 2015